Naloxone gel - Mucodel

Drug Profile

Naloxone gel - Mucodel

Alternative Names: Exonal; Naloxone buccal gel - Mucodel; Naloxone intranasal gel - Mucodel

Latest Information Update: 16 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mucodel
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Opioid abuse

Most Recent Events

  • 11 Dec 2017 Mucodel completes a pilot clinical trial in Opioid abuse in USA (Intranasal)
  • 15 Mar 2017 Mucodel Pharma receives patent allowance for its naloxone buccal gel in USA
  • 21 Sep 2016 Phase-I clinical trials in Opioid abuse in USA before Sep 2016 (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top